Q: The stock almost doubled between May and September and has gone up and down since. Does it have potential to get back to its September high, and possibly higher?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: are they aligned with shareholders what is the insider ownership
Q: What is your outlook on TDOC? Is there another stock in the Healthcare space that you would prefer or stay with TDOC for the long term?
Thanks for your service?
Thanks for your service?
Q: I am wondering if the recent $65M debenture deal is significant.
Is well looking at another significant acquisition or is it simply to meet the request of a major investor ?
Thank You
Is well looking at another significant acquisition or is it simply to meet the request of a major investor ?
Thank You
Q: With CloudMD set to acquire MindBeacon ($1.22 cash + 2.285 share conversion), what would you suggest to current MBCN shareholders?
Would you suggest a partial exit at the current MBCN share price or would you hold DOC.V shares after close?
Would you suggest a partial exit at the current MBCN share price or would you hold DOC.V shares after close?
Q: Hi Peter snd staff
A question yesterday asked to rank some stocks -appears you are warming up to Viatris? Some commentators worry about drugs coming off patent - some say it is so cheap it should be re rated? Safe for a long term hold with dividend and done growth?
Thanks for all you do
Dennis
A question yesterday asked to rank some stocks -appears you are warming up to Viatris? Some commentators worry about drugs coming off patent - some say it is so cheap it should be re rated? Safe for a long term hold with dividend and done growth?
Thanks for all you do
Dennis
Q: Would you endorse a sale of GH and buy back in 30 days or are there others in the same space that you would prefer? If so, please list them?
Thanks for your service!
Thanks for your service!
Q: It has been 17 months since the last question on this company. their possible breakthrough re: the treatment of glioblastoma is very encouraging. The stock has been whip-sawing. Your current views?
Thank you
Thank you
Q: CloudMD to Acquire MindBeacon, One of North America's Leading Clinically-Validated iCBT Solutions
What do you think of the deal announced this morning? What would be a good entry price?
What do you think of the deal announced this morning? What would be a good entry price?
Q: Hello Team,
Could you comment on these two securities. Would you prefer one over the other. Are they too similar to own both.
Thank You,
Barry
Could you comment on these two securities. Would you prefer one over the other. Are they too similar to own both.
Thank You,
Barry
Q: Agilent has pulled back from recent highs - what are your overall thoughts of the company and prospects? Thanks.
Q: May you provide an update on this security?
I am down 40%, would you be inclined to hold or crystallize a loss?
Thank you
I am down 40%, would you be inclined to hold or crystallize a loss?
Thank you
Q: Any comment on this potentially promising stock in health care ? In view of many developments in medicine and therapeutics such application of genetics would be likely the future of therapeutic interventions in individual care .
Miroslaw
Miroslaw
Q: BLU ... your opinion on BLU ... risk, future growth, is this a buy ... thx much
Q: Do you have any research available on this company?
-
Regeneron Pharmaceuticals Inc. (REGN $589.48)
-
AbbVie Inc. (ABBV $210.60)
-
Profound Medical Corp. (PRN $6.58)
-
DexCom Inc. (DXCM $82.26)
Q: Hi,
Could I have your top two picks for Healthcare please, which can include the US as I'm low on my US exposure.
Thanks,
Could I have your top two picks for Healthcare please, which can include the US as I'm low on my US exposure.
Thanks,
Q: Hi 5i
Could I please have your overview of DR results and forward look.
Thanks
Could I please have your overview of DR results and forward look.
Thanks
Q: Could you comment on AND's quarter and how they fared with analysts expectations ? Also your assessment of the conference call and anything mentioned about future growth or obstacles foreseen ? The numbers looked good to me but Mr Market doesn't seem to be excited ....Which makes me wonder if there was something in the outlook in the conference call that made investors yawn ......I took a half position before the quarterly results and am considering filling it out now . Would you endorse this ? Thanks for your terrific service .....
Q: May I have your opinion on the latest Financial results released by the Andlauer Group. Thanks.
Q: Please comment on earnings, did management comment on plans for their cash horde in the call?
Regards greg
Regards greg